Tianda Pharmaceuticals Ltd 2018 SR
The report covers the fiscal year from April 1, 2017, to March 31, 2018, detailing the company's performance in environmental, social, and governance areas. Key highlights include the implementation of energy-saving initiatives and wastewater treatment systems at its major production bases in Zhuhai and Kunming. The company achieved significant reductions in emissions, with SO2 and NOx levels remaining well below national standards. Socially, the group focused on workplace safety, employee development, and community investment, including disaster relief efforts after Typhoon Hato and support for local education and healthcare programs.
Company: Tianda Pharmaceuticals Ltd
Sector: Health Care
Country: Hong Kong
Year: 2018
Type: SR
Pages: 21
Tianda Pharmaceuticals Ltd
ESG Report
The report covers the fiscal year from April 1, 2017, to March 31, 2018, detailing the company's performance in environmental, social, and governance areas. Key highlights include the implementation of energy-saving initiatives and wastewater treatment systems at its major production bases in Zhuhai and Kunming. The company achieved significant reductions in emissions, with SO2 and NOx levels remaining well below national standards. Socially, the group focused on workplace safety, employee development, and community investment, including disaster relief efforts after Typhoon Hato and support for local education and healthcare programs.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Apr 1, 2017 - Mar 31, 2018
Fiscal Year
2018
Published
Oct 23, 2018
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Water Consumption